[{"NetIncomeLoss_1_Q2_USD":-150820000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-618000.0,"PrepaidTaxes_0_Q2_USD":5270000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"AccruedRoyaltiesCurrent_0_Q2_USD":7053000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":77200000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":77968000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":159088000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":3623000.0,"BusinessCombinationContingentConsiderationLiability_0_Q2_USD":5200000.0,"BilledContractReceivables_0_Q2_USD":94692000.0,"InterestPaidNet_2_Q2_USD":15032000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":6000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-51905000.0,"PrepaidExpenseNoncurrent_0_Q2_USD":4680000.0,"LiabilitiesFairValueDisclosure_0_Q2_USD":5200000.0,"AssetsCurrent_0_Q2_USD":2459421000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-618000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-44000.0,"Assets_0_Q2_USD":2883043000.0,"ProceedsFromSaleOfIntangibleAssets_2_Q2_USD":108069000.0,"CommonStockSharesIssued_0_Q2_shares":78432246.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":626980000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-44000.0,"GainLossOnDispositionOfIntangibleAssets_2_Q2_USD":108069000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":10000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":10000000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":73688000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":156456000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":756738000.0,"OtherNoncashIncomeExpense_2_Q2_USD":800000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":21860000.0,"ShareBasedCompensation_2_Q2_USD":51640000.0,"Liabilities_0_Q2_USD":1840177000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":72401000.0,"ShortTermInvestments_0_Q2_USD":421349000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":77200000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":77968000.0,"AssetsFairValueDisclosure_0_Q2_USD":1771962000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":721000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-371000.0,"AccountsReceivableNetCurrent_0_Q2_USD":104028000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":135000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":20000.0,"IncreaseDecreaseInDeferredRevenue_2_Q2_USD":794484000.0,"CommonStockValue_0_Q2_USD":8000.0,"Revenues_2_Q2_USD":251037000.0,"Revenues_1_Q2_USD":137363000.0,"RestrictedCashAndInvestmentsNoncurrent_0_Q2_USD":9566000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_1_Q2_USD":27616000.0,"InterestPayableCurrent_0_Q2_USD":1045000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":13004000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":1639959000.0,"OtherAssetsNoncurrent_0_Q2_USD":182980000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":165000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":331000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-151438000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-168356000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":3505165000.0,"IncreaseDecreaseInInventories_2_Q2_USD":8271000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":2070900000.0,"CostsAndExpenses_1_Q2_USD":275716000.0,"CostsAndExpenses_2_Q2_USD":507416000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":336597000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":188522000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":324666000.0,"OtherAssetsCurrent_0_Q2_USD":114435000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":74197000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"RestrictedCashNoncurrent_0_Q2_USD":8565000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-168177000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-150800000.0,"RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_2_Q2_USD":39245000.0,"RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_1_Q2_USD":26019000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":520187000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":75981000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":77200000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":77968000.0,"LiabilitiesCurrent_0_Q2_USD":354896000.0,"AccountsPayableCurrent_0_Q2_USD":91660000.0,"NonoperatingIncomeExpense_2_Q2_USD":88202000.0,"NonoperatingIncomeExpense_1_Q2_USD":-12447000.0,"InterestExpense_2_Q2_USD":27328000.0,"InterestExpense_1_Q2_USD":13713000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":1648524000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":29342000.0,"NetIncomeLoss_2_Q2_USD":-168312000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":153340000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PrepaidInsurance_0_Q2_USD":1371000.0,"GovernmentContractReceivable_0_Q2_USD":470000.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_2_Q2_USD":9032000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":13105000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":1648524000.0,"CashEquivalentsAtCarryingValue_0_Q2_USD":1316268000.0,"IncrementalCommonSharesAttributableToCallOptionsAndWarrants_1_Q2_shares":0.0,"IncrementalCommonSharesAttributableToCallOptionsAndWarrants_2_Q2_shares":0.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":44309000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":5352000.0,"OtherAssetsMiscellaneousNoncurrent_0_Q2_USD":2037000.0,"CommonStockSharesOutstanding_0_Q2_shares":78432246.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":13149000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":804879000.0,"PreferredStockValue_0_Q2_USD":null,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":89311000.0,"InvestmentIncomeInterest_1_Q2_USD":638000.0,"InvestmentIncomeInterest_2_Q2_USD":2777000.0,"InventoryNet_0_Q2_USD":179650000.0,"OtherAssetsMiscellaneousCurrent_0_Q2_USD":3222000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":2883043000.0,"OtherNonoperatingExpense_1_Q2_USD":12447000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":421349000.0,"OperatingIncomeLoss_1_Q2_USD":-138353000.0,"OperatingIncomeLoss_2_Q2_USD":-256379000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":111344000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":211792000.0,"CommonStockSharesAuthorized_0_Q2_shares":198000000.0,"OtherNonoperatingExpense_2_Q2_USD":19867000.0,"LongTermLoansPayable_0_Q2_USD":694156000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":28643000.0,"InventoryWorkInProcessAndRawMaterialsNetOfReserves_0_Q2_USD":100046000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-2462313000.0,"AvailableForSaleSecuritiesTransfersToTradingGrossGains_2_Q2_USD":108069000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":48389000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":28289000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":708476000.0,"StockholdersEquity_0_Q2_USD":1042866000.0,"PreferredStockSharesAuthorized_0_Q2_shares":3333333.0,"OtherLiabilitiesCurrent_0_Q2_USD":14837000.0,"ProfitLoss_2_Q2_USD":-168312000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-1.93,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-2.18,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest_1_Q2_USD":-618000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":51640000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":27616000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":10248000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":9585000.0,"Ticker":"SRPT","CIK":"873303","name":"SAREPTA THERAPEUTICS, INC.","OfficialName":"Sarepta Therapeutics Inc. Common Stock (DE)","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"7117506934.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200805"}]